GSK reported good Q3 results but priced dropped so I bought some more. At this price GSK, I am in regular accumulation mode for GSK.
Currently hold about S$20k+ worth, would like to at least double the holding.
GSK delivers Q3 sales of £7.8 billion, +4% AER, +2% CER Total EPS 24.8p, +49% AER, +46% CER; Adjusted EPS 32.5p, +3% AER, flat CER
http://www.gsk.com/media/4171/q3-2017-results-announcement.pdf
__________
In other portfolio news, topped up my Euro Stoxx 50 ETF, and WPP
No comments:
Post a Comment